Glucagonoma, also known as glucagonoma syndrome, is related to diarrhea and endocrine gland cancer, and has symptoms including diarrhea An important gene associated with Glucagonoma is SST (Somatostatin), and among its related pathways/superpathways are Signal Transduction and Gastrin signaling pathway. The drugs Bevacizumab and Gefitinib have been mentioned in the context of this disorder. Affiliated tissues include pancreas and liver, and related phenotypes are neoplasm of the pancreas and nausea and vomiting